Stockscreener 앱 받기
3.59
0.56%
0.02
시간 외 거래:
3.48
-0.11
-3.06%
전일 마감가:
$3.57
열려 있는:
$3.59
하루 거래량:
286.18K
Relative Volume:
0.71
시가총액:
$179.64M
수익:
$17.63M
순이익/손실:
$-57.71M
주가수익비율:
-2.4257
EPS:
-1.48
순현금흐름:
$-60.45M
1주 성능:
+4.97%
1개월 성능:
-0.28%
6개월 성능:
-15.53%
1년 성능:
-43.46%
1일 변동 폭
$3.48
$3.62
1주일 범위
$3.33
$3.70
52주 변동 폭
$3.075
$6.60
Scpharmaceuticals Inc Stock (SCPH) Company Profile
명칭
Scpharmaceuticals Inc
전화
617-517-0730
주소
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
SCPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCPH
Scpharmaceuticals Inc
|
3.59 | 179.64M | 17.63M | -57.71M | -60.45M | -1.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.11 | 104.84B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.15 | 78.92B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
621.29 | 37.15B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.28 | 30.22B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.79 | 27.76B | 3.30B | -501.07M | 1.03B | -2.1146 |
Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-07 | 개시 | Craig Hallum | Buy |
| 2022-12-01 | 개시 | Cowen | Outperform |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-10-11 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-02 | 개시 | Maxim Group | Buy |
| 2021-09-09 | 개시 | SVB Leerink | Mkt Perform |
| 2019-10-15 | 개시 | H.C. Wainwright | Buy |
| 2019-01-30 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
모두보기
Scpharmaceuticals Inc 주식(SCPH)의 최신 뉴스
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by State Street Corp - Defense World
scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shift From Loss To Profit - Yahoo Finance
Sanctuary Advisors LLC Takes $75,000 Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
27,169 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by XTX Topco Ltd - Defense World
BNP Paribas Financial Markets Has $26,000 Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Charles Schwab Investment Management Inc. Sells 3,312 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
SC Pharmaceuticals Inc (SCPH-Q) QuotePress Release - The Globe and Mail
The Manufacturers Life Insurance Company Invests $57,000 in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
2 "Strong Buy"-Rated Biotech Stocks With 303% To 446% Upside Potential - Barchart
Tscan Therapeutics Inc (TCRX-Q) QuotePress Release - The Globe and Mail
Head to Head Survey: Cyclerion Therapeutics (NASDAQ:CYCN) vs. scPharmaceuticals (NASDAQ:SCPH) - Defense World
Wearable Injector Market Growth in Future Scope 2024-2031 | - openPR
ScPharmaceuticals Stock Falls After Noting Possible FDA Submission Delay - MarketWatch
MetLife Investment Management LLC Grows Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
SCPH (scPharmaceuticals) 9-Day RSI : 45.28 (As of Dec. 04, 2024) - GuruFocus.com
Jefferies cuts scPharmaceuticals stock target, keeps buy rating on Q3 results - Investing.com UK
Suvretta Capital Management LLC Makes New $9.34 Million Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
Rubric Capital Management LP Boosts Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat
scPharmaceuticals (STU:2SX) Cash Flow from Operations : €-64.68 Mil (TTM As of Sep. 2024) - GuruFocus.com
scPharmaceuticals (STU:2SX) Float Percentage Of Total Shares Outstanding : 88.47% (As of Nov. 21, 2024) - GuruFocus.com
scPharmaceuticals (STU:2SX) Intrinsic Value: Projected FCF : €-6.70 (As of Nov. 21, 2024) - GuruFocus.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless - Simply Wall St
Downgrade: Here's How Analysts See scPharmaceuticals Inc. (NASDAQ:SCPH) Performing In The Near Term - Simply Wall St
HC Wainwright Expects Reduced Earnings for scPharmaceuticals - MarketBeat
King Luther Capital Management Corp's Strategic Acquisition in s - GuruFocus.com
Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
500: Something went wrong - Investing.com India
SCPH stock touches 52-week low at $3.24 amid market challenges - Investing.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript - Insider Monkey
scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
The one-year earnings decline has likely contributed toscPharmaceuticals' (NASDAQ:SCPH) shareholders losses of 33% over that period - Simply Wall St
Earnings call: scPharmaceuticals reports robust Q3 growth, eyes FDA nod By Investing.com - Investing.com UK
ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates - MSN
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
scPharmaceuticals Reports Strong Growth in Q3 2024 - TipRanks
ScPharmaceuticals Q3 Loss Widens, Revenue Rises - Marketscreener.com
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
scPharmaceuticals' FUROSCIX Revenue Surges 164% YoY to $10M in Q3, Expands FDA Approval | SCPH Stock News - StockTitan
Certain Common Stock of scPharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2024. - Marketscreener.com
scPharmaceuticals (SCPH) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 - The Manila Times
scPharmaceuticals Sets Q3 2024 Earnings Call for November 13 | SCPH Stock News - StockTitan
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
KING LUTHER CAPITAL MANAGEMENT CORP Expands Stake in scPharmaceu - GuruFocus.com
TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval - Investing.com India
TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval By Investing.com - Investing.com South Africa
Third Time's The Charm For ScPharma? - RTTNews
scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 - GlobeNewswire
Congestive Heart Failure Treatment Market 2034: Clinical - openPR
The Attractiveness of Investing In scPharmaceuticals Inc (SCPH) is Growing - Knox Daily
Scpharmaceuticals Inc (SCPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Scpharmaceuticals Inc 주식 (SCPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Aug 13 '24 |
Buy |
4.00 |
500,000 |
2,000,000 |
5,806,670 |
| Nokes Rachael | CFO and Treasurer |
Aug 06 '24 |
Option Exercise |
0.00 |
10,445 |
0 |
72,851 |
0.60%
2.24%
자본화:
|
볼륨(24시간):